Last Updated: November 14, 2026

Patent: 10,874,708

Summary for Patent: 10,874,708

Title:	Compositions for reducing appetite and craving, increasing satiety, enhancing mood, and reducing stress
Abstract:	A method for enhancing at least one of craving-reduction, mood improvement, avoidance of depression, prevention of weight gain post weight-loss from dieting, reduction of negative side effects produced by anti-appetite drugs and smoke-cessation and promotion of healthy ageing in a person in need thereof, comprising administering a composition to said person, said composition comprising: The composition may comprise a third active ingredient in combination with the Cyperus esculentus extract and mangiferin or norathyriol.
Inventor(s):	Miguel Jiménez del Rio, Julia C. WIEBE, Laura LOPEZ-RIOS, Tanausu VEGA-MORALES, Ruben PEREZ-MACHIN, Alvaro SANCHEZ-RODRIGUEZ, Carlos J. MATEOS, Nigel Peter Gericke
Assignee:	Nektium Pharma SL
Application Number:	US15/402,886
Patent Claims:	see list of patent claims

Details for Patent 10,874,708

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
United Therapeutics Corporation	UNITUXIN	dinutuximab	Injection	125516	March 10, 2015	⤷ Start Trial	2037-01-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,874,708

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Brazil	112019014238	⤷ Start Trial
Canada	3049908	⤷ Start Trial
China	110402138	⤷ Start Trial
European Patent Office	3568130	⤷ Start Trial
Spain	2681996	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.